The target-pathway network illustrated that AKT1, MAPK1, GSK3B, TNF, MTOR, and PTEN were core targets enriched in key signaling pathways that played crucial roles in the treatment of depression by CCHP. Here, MTOR is linked to depressive symptom measurement.